We found that the APE1 T1349G variant genotypes were associated with a moderately increased risk of all cancer types (OR = 1.08, 95%CI = 1.00–1.18 in a dominant model), suggesting that this polymorphism is a low-penetrance risk factor for cancer development [13]. This evidence concerns the gene APEX1 and cancer.